Shenglong Ding

Dr. Shenglong Ding

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2019 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
LJLibo Jiang
Libo Jiang
DSDi‐Han Su
Di‐Han Su
SDShenglong Ding
Shenglong Ding
QZQi‐Chen Zhang
Qi‐Chen Zhang
ZLZe‐Fang Li
Ze‐Fang Li
JDJian Dong
Jian Dong

3 July 2024 in Advanced Materials
Verified
Journal Article
Closed access
YSYun Sun
Yun Sun
SDShenglong Ding
Shenglong Ding
XZXiyuan Zhao
Xiyuan Zhao
DSDadi Sun
Dadi Sun
YYYuhan Yang
Yuhan Yang
MZMingzhu Zhang
Mingzhu Zhang

2 May 2023 in Materials Today Bio
Verified
Journal Article
Open access
WHWen-Hui Huang
Wen-Hui Huang
SDShenglong Ding
Shenglong Ding
XZXi-Yuan Zhao
Xi-Yuan Zhao
KLKai Li
Kai Li
HGHai-Tao Guo
Hai-Tao Guo
Qi GuQi Gu
Qi Gu
Neural tissue engineering (NTE) has made remarkable strides in recent years and holds great promise for treating several devastating neurological disorders. Selecting optimal scaffolding material is crucial for NET design strategies that enable neural and non-neural cell differentiation and axonal growth. Collagen is extensively employed in NTE applications due to the inherent resistance of the nervous system against regeneration, functionalized with neurotrophic factors, antagonists of neural growth inhibitors, and other neural growth-promoting agents. Recent advancements in integrating collagen with manufacturing strategies, such as scaffolding, electrospinning, and 3D bioprinting, provide localized trophic support, guide cell alignment, and protect neural cells from immune activity. This review categorises and analyses collagen-based processing techniques investigated for neural-specific applications, highlighting their strengths and weaknesses in repair, regeneration, and recovery. We also evaluate the potential prospects and challenges of using collagen-based biomaterials in NTE. Overall, this review offers a comprehensive and systematic framework for the rational evaluation and applications of collagen in NTE.

24 March 2020 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
SDShenglong Ding
Shenglong Ding
ZPZhi-Ying Pang
Zhi-Ying Pang
XCXue-Mei Chen
Xue-Mei Chen
ZLZheng Li
Zheng Li
XLXinxin Liu
Xinxin Liu
ZRZhi-Yong Ruan
Zhi-Yong Ruan
Background: Osteoarthritis (OA) is characterized by inflammation and extracellular matrix (ECM) degradation and is one of the most common chronic degenerative joint diseases that causes pain and disability in adults. Urolithin A (UA) has been widely reported for its anti-inflammatory properties in several chronic diseases. However, the effects of UA on OA remain unclear. The aim of the current study was to investigate the anti-inflammatory effects and mechanism of UA in interleukin-1β (IL-1β)-induced chondrocytes. Results: No marked UA cytotoxicity was noted, and UA protected cartilage from damage following IL-1β stimulation in micromasses. Moreover, UA promoted the expression of anabolic factors including Sox-9, Collagen II, and Aggrecan while inhibiting the expression of catabolic factors such as matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) in rat chondrocytes. Protective effects of UA were also observed in ex vivo organ culture of articular cartilage. Mechanistically, IL-1β significantly activated and upregulated the expression of p-ERK 1/2, p-JNK, p-P38, and p-P65, while UA protected chondrocytes against IL-1β-induced injury by activating the mitogen-activated kinase (MAPK)/nuclear factor-κB (NF-κB) signaling pathways. Conclusion: Our results provide the evidence that UA could attenuate IL-1β-induced cell injury in chondrocytes via its anti-inflammatory action. UA may be a promising therapeutic agent in the treatment of OA.

11 August 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
HZHongjun Zhuang
Hongjun Zhuang
MZMengyao Zhao
Mengyao Zhao
SDShenglong Ding
Shenglong Ding
LLLingyan Liu
Lingyan Liu
WYWei Yuan
Wei Yuan
TYTao Yi
Tao Yi

26 April 2019 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
PDF file
DSDihan Su
Dihan Su
SDShenglong Ding
Shenglong Ding
WSWeiliang Shi
Weiliang Shi
XHXuefeng Huang
Xuefeng Huang
LJLibo Jiang
Libo Jiang
Recently, regenerated silk fibroin is one of the most investigated silk-based materials for tissue engineering. However, it needs complex preparation process and will irresistibly denature to solid state with time, which is the biggest challenge to produce in large scale and widely use it as commercial material. In this work, industrially produced sericin, silk fibroin amino acid, and silk fibroin powder were investigated on its physico–chemical and biological properties compared with laboratory prepared regenerated silk fibroin, in order to excavate the potential application in biomedical and therapeutical fields. The results showed that sericin may be the most suitable silk materials to use as an alternative in tissue engineering compared with regenerated silk fibroin. It was found that sericin can absorb UV in the range of 223–300 nm, inhibit tyrosinase, resist to free radicals, and retain water capacity similar to hyaluronic acid. Importantly, cell experiment on human fibroblast showed that sericin (0.05 wt%) could stimulate cell proliferation and obviously up-regulate the expression of collagen type I, collagen type III, and hyaluronidase I compared with the control at seven days, which is the closest equivalent to regenerated silk fibroin. These results suggested that sericin might be a valuable ingredient for skin repair on tissue engineering.